Journal review flags health inequities limiting semaglutide access in obesity care

The wire

1. 01A commentary in Postgraduate Medical Journal, published 22 September 2026, examines health inequities that restrict access to semaglutide for obesity management.
2. 02Clinicians and telehealth operators face patients who qualify clinically but cannot obtain or sustain therapy because of cost and coverage barriers.
3. 03The piece is a narrative commentary rather than new data, so specific access figures and proposed remedies should be read from the full text.

From the source

Beyond efficacy: health inequities limiting access to semaglutide for obesity management

Postgraduate medical journal · 2026 Sep 22 · Islam K, Hassan M et al.